1,131 results on '"Dammacco, Franco"'
Search Results
2. STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure
3. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements
4. The eye is a common site of granulomatosis with polyangiitis. A collaborative study
5. Cryoglobulinemia
6. Highlights in clinical medicine—Giant cell arteritis, polymyalgia rheumatica and Takayasu’s arteritis: pathogenic links and therapeutic implications
7. Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review
8. Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study
9. Takayasu arteritis: a cohort of Italian patients and recent pathogenetic and therapeutic advances
10. Ocular sarcoidosis: clinical experience and recent pathogenetic and therapeutic advancements
11. Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease
12. CD5/CD20 expression on circulating B cells in HCV-related chronic hepatitis and mixed cryoglobulinemia
13. Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy
14. Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target?
15. Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trial
16. HCV-Related Cryoglobulinemic Vasculitis: An Overview
17. Vasculitis in Connective Tissue Diseases
18. Granulomatosis with Polyangiitis (Wegener’s)
19. Microscopic Polyangiitis
20. Animal Models of ANCA-Associated Vasculitides
21. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis
22. Ocular manifestations of cryoglobulinemia: a reappraisal
23. Antiviral Therapy in HCV-Positive Non-Hodgkin’s Lymphoma: Pathogenetic Implications
24. PIRR Therapy in HCV-Related Mixed Cryoglobulinemia
25. The Higher Prevalence of B-Cell Non-Hodgkin’s Lymphoma in HCV-Positive Patients with and Without Cryoglobulinemia
26. Role of B-Cell-Attracting Chemokine-1 in HCV-Related Cryoglobulinemic Vasculitis
27. Mechanisms of Cell Entry of Hepatitis C Virus
28. The Pivotal Role of C1qR in Mixed Cryoglobulinemia
29. Introductory Remarks
30. Gene Fusion in NSCLC
31. Bone Metastases from Solid Tumors
32. Preface
33. List of Contributors
34. Cancer Stem Cells in Multiple Myeloma and the Development of Novel Therapeutic Strategies
35. From the Double Helix to Oncogenomics and Precision Cancer Medicine
36. Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial
37. Supplementary Figure 3 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
38. Supplementary Figure 5 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
39. Supplementary Figure 1 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
40. Supplementary Table 2 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
41. Supplementary Data from Lenalidomide Restrains Motility and Overangiogenic Potential of Bone Marrow Endothelial Cells in Patients with Active Multiple Myeloma
42. Supplementary Figure S1 from Endothelial Differentiation of Hematopoietic Stem and Progenitor Cells from Patients with Multiple Myeloma
43. Supplementary Figure 2 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
44. Supplementary Data from Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma
45. Supplementary Methods, Figure Legend from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
46. Supplementary Figure 4 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
47. Supplementary Table 1 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
48. Supplementary Table 2 from β3 Integrin Subunit Mediates the Bone-Resorbing Function Exerted by Cultured Myeloma Plasma Cells
49. Supplementary Table 1 from β3 Integrin Subunit Mediates the Bone-Resorbing Function Exerted by Cultured Myeloma Plasma Cells
50. Data from β3 Integrin Subunit Mediates the Bone-Resorbing Function Exerted by Cultured Myeloma Plasma Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.